272 related articles for article (PubMed ID: 33479496)
21. Integrated genomic analyses in PDX model reveal a cyclin-dependent kinase inhibitor Palbociclib as a novel candidate drug for nasopharyngeal carcinoma.
Hsu CL; Lui KW; Chi LM; Kuo YC; Chao YK; Yeh CN; Lee LY; Huang Y; Lin TL; Huang MY; Lai YR; Yeh YM; Fan HC; Lin AC; Lu YJ; Hsieh CH; Chang KP; Tsang NM; Wang HM; Chang AY; Chang YS; Li HP
J Exp Clin Cancer Res; 2018 Sep; 37(1):233. PubMed ID: 30236142
[TBL] [Abstract][Full Text] [Related]
22. Natural Variations in BRLF1 Promoter Contribute to the Elevated Reactivation Level of Epstein-Barr Virus in Endemic Areas of Nasopharyngeal Carcinoma.
Zhang JB; Huang SY; Wang TM; Dong SQ; He YQ; Zheng XH; Li XZ; Wang F; Jianbing M; Jia WH
EBioMedicine; 2018 Nov; 37():101-109. PubMed ID: 30420297
[TBL] [Abstract][Full Text] [Related]
23. SPLUNC1 reduces the inflammatory response of nasopharyngeal carcinoma cells infected with the EB virus by inhibiting the TLR9/NF-κB pathway.
Ou C; Sun Z; Zhang H; Xiong W; Ma J; Zhou M; Lu J; Zeng Z; Bo X; Chen P; Li G; Li X; Li X
Oncol Rep; 2015 Jun; 33(6):2779-88. PubMed ID: 25891128
[TBL] [Abstract][Full Text] [Related]
24. Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency.
Dheekollu J; Malecka K; Wiedmer A; Delecluse HJ; Chiang AK; Altieri DC; Messick TE; Lieberman PM
Oncotarget; 2017 Jan; 8(5):7248-7264. PubMed ID: 28077791
[TBL] [Abstract][Full Text] [Related]
25. Genotypic Characterization of Epstein Barr Virus in Blood of Patients with Suspected Nasopharyngeal Carcinoma in Ghana.
Ayee R; Ofori MEO; Tagoe EA; Languon S; Searyoh K; Armooh L; Bilson-Amoah E; Baidoo K; Kitcher E; Wright E; Quaye O
Viruses; 2020 Jul; 12(7):. PubMed ID: 32708700
[TBL] [Abstract][Full Text] [Related]
26. Translational genomics of nasopharyngeal cancer.
Tsang CM; Lui VWY; Bruce JP; Pugh TJ; Lo KW
Semin Cancer Biol; 2020 Apr; 61():84-100. PubMed ID: 31521748
[TBL] [Abstract][Full Text] [Related]
27. Circulating Epstein-Barr virus microRNAs miR-BART7 and miR-BART13 as biomarkers for nasopharyngeal carcinoma diagnosis and treatment.
Zhang G; Zong J; Lin S; Verhoeven RJ; Tong S; Chen Y; Ji M; Cheng W; Tsao SW; Lung M; Pan J; Chen H
Int J Cancer; 2015 Mar; 136(5):E301-12. PubMed ID: 25213622
[TBL] [Abstract][Full Text] [Related]
28. Novel roles and therapeutic targets of Epstein-Barr virus-encoded latent membrane protein 1-induced oncogenesis in nasopharyngeal carcinoma.
Tao Y; Shi Y; Jia J; Jiang Y; Yang L; Cao Y
Expert Rev Mol Med; 2015 Aug; 17():e15. PubMed ID: 26282825
[TBL] [Abstract][Full Text] [Related]
29. Constitutive activation of distinct NF-κB signals in EBV-associated nasopharyngeal carcinoma.
Chung GT; Lou WP; Chow C; To KF; Choy KW; Leung AW; Tong CY; Yuen JW; Ko CW; Yip TT; Busson P; Lo KW
J Pathol; 2013 Nov; 231(3):311-22. PubMed ID: 23868181
[TBL] [Abstract][Full Text] [Related]
30. Targeting Epstein-Barr virus oncoprotein LMP1-mediated high oxidative stress suppresses EBV lytic reactivation and sensitizes tumors to radiation therapy.
Hu J; Li Y; Li H; Shi F; Xie L; Zhao L; Tang M; Luo X; Jia W; Fan J; Zhou J; Gao Q; Qiu S; Wu W; Zhang X; Liao W; Bode AM; Cao Y
Theranostics; 2020; 10(26):11921-11937. PubMed ID: 33204320
[TBL] [Abstract][Full Text] [Related]
31. Viral markers in nasopharyngeal carcinoma: A systematic review and meta-analysis on the detection of p16
Tham T; Machado R; Russo DP; Herman SW; Teegala S; Costantino P
Am J Otolaryngol; 2021; 42(1):102762. PubMed ID: 33202328
[TBL] [Abstract][Full Text] [Related]
32. Quantitation of DNA methylation in Epstein-Barr virus-associated nasopharyngeal carcinoma by bisulfite amplicon sequencing.
Zhao W; Mo Y; Wang S; Midorikawa K; Ma N; Hiraku Y; Oikawa S; Huang G; Zhang Z; Murata M; Takeuchi K
BMC Cancer; 2017 Jul; 17(1):489. PubMed ID: 28716111
[TBL] [Abstract][Full Text] [Related]
33. EBV-encoded miRNAs can sensitize nasopharyngeal carcinoma to chemotherapeutic drugs by targeting BRCA1.
Lung RW; Tong JH; Ip LM; Lam KH; Chan AW; Chak WP; Chung LY; Yeung WW; Hau PM; Chau SL; Tsao SW; Lau KM; Lo KW; To KF
J Cell Mol Med; 2020 Nov; 24(22):13523-13535. PubMed ID: 33074587
[TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr Virus-Based Nasopharyngeal Carcinoma (NPC) Risk Prediction Scores Are Elevated in NPC Multiplex Family Members in Taiwan.
Lee MH; Huang YH; Coghill AE; Liu Z; Yu KJ; Hsu WL; Chien YC; Wang CP; Chen TC; Chen CJ; Hildesheim A
J Infect Dis; 2021 Feb; 223(3):441-444. PubMed ID: 32614957
[TBL] [Abstract][Full Text] [Related]
35. Epstein-Barr virus infection induces indoleamine 2,3-dioxygenase expression in human monocyte-derived macrophages through p38/mitogen-activated protein kinase and NF-κB pathways: impairment in T cell functions.
Liu WL; Lin YH; Xiao H; Xing S; Chen H; Chi PD; Zhang G
J Virol; 2014 Jun; 88(12):6660-71. PubMed ID: 24696473
[TBL] [Abstract][Full Text] [Related]
36. A primary nasopharyngeal three-dimensional air-liquid interface cell culture model of the pseudostratified epithelium reveals differential donor- and cell type-specific susceptibility to Epstein-Barr virus infection.
Ziegler P; Tian Y; Bai Y; Abrahamsson S; Bäckerholm A; Reznik AS; Green A; Moore JA; Lee SE; Myerburg MM; Park HJ; Tang KW; Shair KHY
PLoS Pathog; 2021 Apr; 17(4):e1009041. PubMed ID: 33914843
[TBL] [Abstract][Full Text] [Related]
37. Epstein-Barr virus BALF3 mediates genomic instability and progressive malignancy in nasopharyngeal carcinoma.
Chiu SH; Wu CC; Fang CY; Yu SL; Hsu HY; Chow YH; Chen JY
Oncotarget; 2014 Sep; 5(18):8583-601. PubMed ID: 25261366
[TBL] [Abstract][Full Text] [Related]
38. Epstein-Barr Virus DNA in Nasopharyngeal Carcinoma: A Brief Review.
Xue F; He X
Methods Mol Biol; 2020; 2204():99-107. PubMed ID: 32710318
[TBL] [Abstract][Full Text] [Related]
39. Clinical utility of circulating Epstein-Barr virus DNA analysis for the management of nasopharyngeal carcinoma.
Fung SY; Lam JW; Chan KC
Chin Clin Oncol; 2016 Apr; 5(2):18. PubMed ID: 27121878
[TBL] [Abstract][Full Text] [Related]
40. Multiplex Epstein-Barr virus BALF2 genotyping detects high-risk variants in plasma for population screening of nasopharyngeal carcinoma.
Miller JA; Sahoo MK; Yamamoto F; Huang C; Wang H; Zehnder JL; Le QT; Pinsky BA
Mol Cancer; 2022 Jul; 21(1):154. PubMed ID: 35902864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
